KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Arbutus Biopharma (ABUS) over the last 16 years, with Sep 2025 value amounting to $191.7 million.

  • Arbutus Biopharma's Shares Outstanding (Weighted Average) rose 1.54% to $191.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $191.7 million, marking a year-over-year increase of 1.54%. This contributed to the annual value of $189.5 million for FY2024, which is 13.00% up from last year.
  • Latest data reveals that Arbutus Biopharma reported Shares Outstanding (Weighted Average) of $191.7 million as of Q3 2025, which was up 0.09% from $191.5 million recorded in Q2 2025.
  • In the past 5 years, Arbutus Biopharma's Shares Outstanding (Weighted Average) ranged from a high of $191.7 million in Q3 2025 and a low of $95.6 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $180.8 million, with a median of $188.7 million in 2024.
  • Data for Arbutus Biopharma's Shares Outstanding (Weighted Average) shows a peak YoY surged of 55.51% (in 2022) over the last 5 years.
  • Arbutus Biopharma's Shares Outstanding (Weighted Average) (Quarterly) stood at $135.3 million in 2021, then climbed by 15.67% to $156.5 million in 2022, then climbed by 7.18% to $167.7 million in 2023, then climbed by 13.00% to $189.5 million in 2024, then increased by 1.54% to $191.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $191.7 million in Q3 2025, compared to $191.5 million in Q2 2025 and $191.5 million in Q1 2025.